Award-linked funding and rank by fiscal year
Fiscal year	Linked awards	Records	Rank
2011	$299,997	1	#26,384
2012	$577,797	2	#13,681
2013	$223,891	1	#30,168
2014	$300,000	1	#26,021
2015	$101,021	1	#36,236
2021	$709,155	2	#14,637
2022	$919,785	2	#10,906
2023	$2,165,747	2	#3,286

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

Publications

A verified OpenAlex publication list is not yet available for this researcher.

Loading publications…

Current affiliation: Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity: Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD: No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage: FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH award records listing Rotolo, Jim as a PI. Multi-PI records show the full award amount for context.

2R44CA265503-02A1R44Contact PI
Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer
Sapience Therapeutics, Inc.
$1.4M
award amount
5R44CA250786-03R44Contact PI
Efficacy and PK/PD of a C/EBP beta antagonist in orthotopic breast cancer
Sapience Therapeutics, Inc.
$803.5K
award amount

Organizations that administered FY2023 awards listing Rotolo, Jim as a PI.

FY2023 award administered by Sapience Therapeutics, Inc. (NY).

Computed from the fiscal years currently available in ScienceDex.

Search NIH-funded principal investigators by topic, department, or activity.

Compare median NIH grant budgets across departments, mechanisms, and years.